Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Photorefraction Screener Snapsight in Comparison With Cycloplegia Table-top Autorefractor in Ametropia in Pediatric Population Between 3 and 8yo, Multicenter French Study.

NCT06882408 is registered in ClinicalTrials.gov with Essilor International as lead sponsor.

NCT NCT06882408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06882408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Photorefraction Screener Snapsight in Comparison With Cycloplegia Table-top Autorefractor in Ametropia in Pediatric Population Between 3 and 8yo, Multicenter French Study.
Lead sponsor
Essilor International
Phase
Not applicable
Overall status
Recruiting
Start date
April 30, 2025
Completion date
December 31, 2025
Enrollment
315 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ametropia, myopia; astigmatism, myopia; refractive error